Catalent
CTLT
#1737
Rank
โ‚ฌ9.89 B
Marketcap
54,52ย โ‚ฌ
Share price
0.00%
Change (1 day)
3.45%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Market capitalization of Catalent (CTLT)

Last known market cap: โ‚ฌ9.89 Billion

On February 19, 2025 Catalent had a market cap of โ‚ฌ9.89 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalent from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ9.89 B-10.62%
2024โ‚ฌ11.07 B50.81%
2023โ‚ฌ7.34 B-2.77%
2022โ‚ฌ7.55 B-62.68%
2021โ‚ฌ20.23 B45.22%
2020โ‚ฌ13.93 B89.4%
2019โ‚ฌ7.35 B85.38%
2018โ‚ฌ3.96 B-12.75%
2017โ‚ฌ4.54 B42.26%
2016โ‚ฌ3.19 B12.17%
2015โ‚ฌ2.85 B0.43%
2014โ‚ฌ2.83 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Supernus Pharmaceuticals
SUPN
โ‚ฌ2.24 B-77.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚ฌ0.64 B-93.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
โ‚ฌ8.85 B-10.51%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
โ‚ฌ0.68 B-93.10%๐Ÿ‡บ๐Ÿ‡ธ USA